May 10, 2011 -- In a 13G filing on XENOPORT (Nasdaq: XNPT), FMR LLC, the parent of mutual fund giant Fidelity, disclosed a 14.99%, or 5,300,029 shares, stake in the company.
The firm held just 564,200 shares at the end of Q4.
XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the bodys natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs.
